Integrated Patient Avatars for Guiding Systemic Therapy Treatments in Metastatic Breast Ca
The investigators propose to use clinically validated patient avatar technology ("PDXovo") that can test multiple drugs against patients' cancers to identify the most promising systemic therapy for each individual.
| Condition(s) | Breast Cancer, Breast Neoplasms, Metastatic Breast Cancer, Cancer, Breast |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | The investigators propose to use clinically validated patient avatar technology ("PDXovo") that can test multiple drugs against patients' cancers to identify the most promising systemic therapy for each individual. |
| Who can participate | Inclusion Criteria: 1. Age 18+. 2. Metastatic breast cancer irrespective of subtype. 3. Measurable disease as per RECIST 1.1 criteria. 4. Metastatic disease involving the lymph nodes and/or visceral organs is required. 5. Willingness to undergo a biopsy prior to the start of planned systemic therapy. Exclusion Criteria: 1. Lack of feasibility to obtain a core biopsy of a metastatic site other than the bone (e.g. a metastatic lesion cannot be safely sampled due to proximity to vasculature). 2. Inability to provide informed consent. |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | Sunnybrook Health Sciences Centre |
| Locations | Toronto, Ontario, Canada |
| Start date | 2021-07-21 |
| NCT ID | NCT04608357 |
| Official listing | https://clinicaltrials.gov/study/NCT04608357 |